生物膜处理市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00015873
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Biofilms Treatment Market Scope 2031

Buy Now

2021 年生物膜处理市场规模为 18.2 亿美元,预计到 2031 年将从 2023 年的 XX 亿美元增至 38.8 亿美元。预计 2023-2031 年市场复合年增长率为 8.0%。产品发布和产品批准以及新技术开发等日益增长的战略发展可能仍是生物膜处理市场的关键趋势。

 

生物膜处理市场分析

伤口和感染的发生率不断上升,以及生物膜在医疗器械上的扩散,增加了对生物膜治疗的需求,从而推动了全球市场的发展。此外,生物膜的日益普及是另一个因素,预计在预测期内将增加市场的增长。根据一些研究,60% 到 100% 的慢性伤口样本中存在生物膜。这一因素代表了生物膜在慢性伤口中更快、更空间化的分布,这需要对生物膜进行最佳治疗。技术改进、新产品的开发以及生物膜治疗领域新参与者的进入可能会在全球范围内扩大市场。与生物膜和抗生素耐药性相关的感染增加,以及先进伤口护理产品的高成本和低采用率等因素,也是阻碍全球生物膜治疗市场整体增长的潜在制约因素。  

 

生物膜处理市场概况

医疗支出不断增加、人口老龄化导致慢性伤口更容易发生、新产品的推出以及有利的报销方案推动了市场增长。监管机构越来越认识到生物膜相关感染对公共健康的影响。正在制定严格的法规和指南来预防和治疗生物膜相关感染,这增加了对合规生物膜治疗解决方案的需求。公司积极追求技术进步和创新,以改进传统方法之外的生物膜治疗。这些创新可能包括开发具有改进抗菌性能的先进伤口敷料、集成智能材料以检测和对抗生物膜,以及探索针对生物膜中嵌入的细菌的靶向药物输送系统。此外,目前正在进行研究工作,以利用生物技术和纳米技术等新技术来开发更有效、更高效的生物膜治疗解决方案。

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

生物膜处理市场:

生物膜处理市场
  • Biofilms Treatment Market
    复合年增长率(2023 - 2031)
    8.0%
  • 2021 年市场规模
    18.2 亿美元
  • 2031 年市场规模
    38.8 亿美元

市场动态

增长动力
  • 慢性、手术和创伤性伤口的发病率不断上升
  • 烧伤数量不断增加
未来的趋势
  • 治疗伤口的费用高昂
机会
  • 新技术开发

关键人物;主力;重要一员

  • Mimedx 集团公司
  • 康威泰克集团
  • 康乐保公司
  • Mölnlycke 医疗保健公司
  • Organogenesis 控股公司
  • Integra Lifesciences 控股公司
  • B. Braun Melsungen AG
  • 保罗·哈特曼股份公司
  • 美德莱恩工业公司
  • 史密斯和侄子有限公司

区域概况

Biofilms Treatment Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Biofilms Treatment Market产品
  • 清创设备
  • 纱布和敷料
  • 移植物和基质
  • 其他的
Biofilms Treatment Market伤口类型
  • 创伤和手术伤口
  • 糖尿病足溃疡
  • 压疮
  • 腿部静脉溃疡
  • 其他的
Biofilms Treatment Market最终用户
  • 医院
  • 家庭护理设置
  • 其他的
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

生物膜处理市场驱动因素和机遇

 

慢性、外科和创伤性伤口发病率上升有利于市场

根据国际糖尿病联合会的研究——2019 年全球和地区糖尿病患病率估计以及 2030 年和 2045 年预测——2019 年糖尿病患病率约为 9.3%,约有 4.63 亿人。预计到 2030 年将达到 10.2%,约有 5.78 亿人。生物膜还会严重影响囊性纤维化 (CF) 患者的肺部和消化系统。全球有超过 70,000 人患有 CF,其中约 30,000 人居住在美国。CF 肺中的生物膜对抗生素治疗具有很强的耐药性。它们对 CF 的整体经济影响贡献巨大,全球每年估计达 75.09 亿美元。此外,先进的医疗技术导致手术数量增加。根据国家医院感染监测系统的数据,美国每年执行约 2700 万例手术,其中约 5% 导致手术部位感染。

 

新兴经济体研究的增加——生物膜处理市场增长的机会

各个领域对微生物生物膜重要性的认识不断提高,这为开发转化研究中的创新技术提供了新的机会,这些技术可以解决微生物生物膜的有害影响并发挥其益处。正在进行的研究侧重于开发可与抗生素一起使用以对抗感染的新型化合物。需要先进的策略或创新方法来预防和根除临床上重要的感染,尤其是在纳米尺度上。了解生物膜如何促进感染和抗生素耐药性对于开发治疗院内病原体感染的有效方法至关重要。同时实现诊断和治疗的先进多功能纳米材料的合成已成为当代研究的热门领域。转录组学、代谢组学和基于转座子的下一代测序的进展可能会揭示生物膜研究的新遗传靶点。

与此同时,必须发现针对生物膜特定细菌成分的新型抗生物膜剂。基于纳米颗粒的抗生物膜剂代表了一个新兴的研究领域,在对抗细菌生物膜方面已显示出良好的效果,尤其是在使用多种药剂时。2021 年 4 月,密歇根州立大学获得默多克信托基金 513,000 美元的资助,扩大了其生物膜研究能力。因此,正在进行的研究和调查预计将对生物膜治疗产生积极影响,从而为市场增长提供有利可图的机会。

 

生物膜处理市场报告细分分析

有助于得出生物膜治疗市场分析的关键部分是产品、伤口类型和最终用户。

  • 根据产品,生物膜治疗市场分为清创设备、纱布和敷料、移植物和基质等。纱布和敷料部分在 2023 年占据了最大的市场份额,预计同一部分在预测期内的复合年增长率最高。
  • 根据伤口类型,市场细分为创伤和手术伤口、糖尿病足溃疡、压疮、静脉性腿部溃疡和其他伤口。创伤和手术伤口部分在 2023 年占据了最大的市场份额,预计同一部分在 2023-2031 年期间的复合年增长率最高。
  • 就终端用户而言,市场分为医院、家庭护理机构和其他终端用户。医院部门在 2023 年占据了最大的市场份额。此外,预计同一部门在预测期内的复合年增长率最高。

 

生物膜处理市场份额(按地区)分析

生物膜处理市场报告的地理范围主要分为五个区域:北美、亚太、欧洲、中东和非洲、南美/南美和中美。

北美主导着生物膜治疗市场。北美市场的增长归因于糖尿病患病率的上升以及提供伤口护理解决方案的协会的存在。在北美,生物技术部门在开发生物膜治疗方面发挥着重要作用。与全球糖尿病发病率相比,糖尿病 (DM) 在美国被认为是一种流行病。随着糖尿病患者数量的增加,预计相关并发症也会增加。各种组织和期刊都发表了治疗和闭合 DFU 的首选方法。然而,尽管有建议的指导方针,但在美国,只有 50% 的糖尿病足溃疡在一年内痊愈。加拿大伤口协会(Wounds Canada,前身为加拿大伤口护理协会)一个非营利组织,致力于促进加拿大伤口预防和管理。该组织主要关注四个关键领域:教育、研究、宣传和意识以及伙伴关系。墨西哥伤口护理和愈合协会是一家非营利性民间组织,由墨西哥致力于研究伤口和造口的多学科专家组成。该协会在医务人员的帮助下,提倡全面护理和获得伤口和造口治疗,以改善患者的生活质量。预计亚太地区未来几年将以最高的复合年增长率增长。  

 

生物膜处理市场报告范围

报告属性细节
2021 年市场规模18.2亿美元
2031 年市场规模38.8亿美元
全球复合年增长率(2023 - 2031)8.0%
历史数据2021-2022
预测期2024-2031
涵盖的领域按产品
  • 清创设备
  • 纱布和敷料
  • 移植物和基质
  • 其他的
按伤口类型
  • 创伤和手术伤口
  • 糖尿病足溃疡
  • 压疮
  • 腿部静脉溃疡
  • 其他的
按最终用户
  • 医院
  • 家庭护理设置
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • Mimedx 集团公司
  • 康威泰克集团
  • 康乐保公司
  • Mölnlycke 医疗保健公司
  • Organogenesis 控股公司
  • Integra Lifesciences 控股公司
  • B. Braun Melsungen AG
  • 保罗·哈特曼股份公司
  • 美德莱恩工业公司
  • 史密斯和侄子有限公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

生物膜处理市场新闻和最新发展

生物膜处理市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下是生物膜处理市场的发展列表:

  • 囊性纤维化基金会向 Clarametyx Biosciences 投资高达 500 万美元,用于开发 CMTX-101,这种药物可以帮助治疗难以治疗的细菌,例如慢性铜绿假单胞菌,这是囊性纤维化患者肺部感染的主要原因。(囊性纤维化基金会,新闻,2024 年)
  • Trellis Bioscience Inc. 是一家专注于发现和开发天然人类单克隆抗体的先锋生物技术公司,该公司宣布其主要抗体候选药物 TRL1068 已获得美国食品药品管理局 (FDA) 的快速通道和 QIDP 资格。(来源:Trellis Bioscience, Inc.,新闻,2024 年)
  • Asep Medical Holdings Inc. 宣布使用人工智能 (AI) 来开发针对常见生物膜感染和快速败血症诊断的新疗法和改良疗法。(来源:ASEP Medical Holdings Inc.,新闻,2024 年)
  • Medline 和 OMNIA Partners 宣布建立新的采购合作伙伴关系。该协议为公共部门机构提供了医疗外科产品组合成本节约。符合条件的公共机构包括州、县和地方政府、初级和高等教育系统以及公共安全服务,将能够利用 Medline 超过 300,000 种医疗用品的全部产品组合。(Medline Industries, LP,新闻稿,2022 年)

 

生物膜处理市场报告覆盖范围和交付成果

“生物膜处理市场规模和预测(2021-2031)”报告对以下领域进行了详细的市场分析:

  • 范围内所有主要细分市场的全球、区域和国家层面的市场规模和预测
  • 市场动态,如驱动因素、限制因素和关键机遇
  • 未来主要趋势
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 全球和区域市场分析涵盖关键市场趋势、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热点图分析、知名参与者和最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

  • Mimedx Group Inc.
  •  Convatec Group Plc
  •  Coloplast A/S
  •  Mölnlycke Healthcare AB
  •  Organogenesis Holdings Inc.
  •  Integra Lifesciences Holdings Corporation
  •  B. Braun Melsungen AG
  •  Paul Hartmann AG
  •  Medline Industries Inc.
  •  Smith & Nephew Plc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..